Scribe Therapeutics has revealed a strategic collaboration with Sanofi for the use of Scribe’s CRISPR genome editing technologies to enable genetic modification of novel natural killer (NK) cell therapies...

View the Online Magazine

Launches

Peli BioThermal launches Crēdo™ Go cold chain shipping solution

Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest reusable, flexible temperature controlled shipping solution. Crēdo™ Go is designed...

ACG to launch German process laboratory in 2023

Following the success of its first-to-market laboratory for process development in India, ACG (the world’s biggest integrated pharmaceutical and nutraceutical manufacturing solutions provider), is...

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Beckman Coulter, a global clinical diagnostics leader, has announced a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG: “The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving”

The current crisis in Europe has led to increasing energy insecurity and shortages of raw materials, which are creating severe pharmaceutical manufacturing supply line...

Advanco partners with Vantage to deliver the first interoperable pharmaceutical traceability solution

Advanco, one of the globe’s leading pharmaceutical track and trace solution providers, has announced the launch of ARC/QU4RTET, the pharmaceutical sector’s first open, interoperable,...

Shionogi signs agreement with NHS England to begin innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (Cefiderocol)

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announced that Shionogi B.V. had signed an agreement with NHS England...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes commitment to...

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin), has announced that Luforbec (beclomethasone / formoterol) 100/6 pressurised metered dose inhaler (pMDI)...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Scribe Therapeutics reveals research collaboration with Sanofi to accelerate breakthrough CRISPR-based cell therapies for cancer

Scribe Therapeutics has revealed a strategic collaboration with Sanofi for the use of Scribe’s CRISPR genome editing technologies to enable genetic modification of novel...

Navigo and Mannin sign agreement to develop innovative affinity ligand against a novel drug for the treatment of COVID-19

Navigo Proteins GmbH (Navigo) and Mannin GmbH, a subsidiary of Mannin Research Inc. (MRI), have entered into an agreement to develop a Precision X...

AVROBIO receives rare pediatric disease designation from U.S. FDA for first gene therapy in development for cystinosis

The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to AVROBIO's AVR-RD-04, an investigational gene therapy for the treatment of...

Promising MND drug helps slow disease progression and benefits patients physically

Scientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of...

Jasper receives FDA Fast Track Designation for monoclonal antibody to treat patients with severe combined immunodeficiency undergoing allogeneic hematopoietic stem cell transplant

Jasper Therapeutics' JSP191, an anti-CD117 monoclonal antibody, has received fast track designation from the U.S. Food and Drug Administration (FDA) for the treatment of...

Appointments